Titlebook: Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer; Lisa A. Newman,Jessica M. Bensenhaver Book 2015 Springer Science+Busi

Aggrandize

Pathology of Ductal Carcinoma In Situ: Features and Diagnostic Challenges,al excisions and needle core biopsies. It discusses the current grading system and it is focused particularly on lesions that are challenging to diagnose in daily pathology practice and that imply different treatment approaches. These topics include atypical ductal hyperplasia (ADH), pleomorphic lob

Magisterial

想象

罵人有污點

Extent and Role of Margin Control for DCIS Managed by Breast-Conserving Surgery,uvant radiation therapy. The optimal margin minimizes the potential residual disease in the breast and the risk of local recurrence while maximizing the cosmetic outcome. Studies consistently report worse local control for positive margins but are inconsistent in identifying a negative margin width

類似思想

Ductal Carcinoma In Situ Treated with Breast-Conserving Surgery Alone,lished by high caliber prospective randomized trials; however, no survival benefit was seen. For this reason, some argue that radiation therapy is overtreatment for certain DCIS cases and that it is appropriate for select subgroups to be treated with breast-conserving surgery alone. There have been

Adulterate

DCIS Managed with BCS: Whole-Breast XRT vs. Partial Breast XRT, in situ (DCIS). Over the past few decades, several randomized trials have demonstrated a 50?% reduction in the risk of local recurrence with adjuvant radiotherapy and recent prospective studies demonstrate higher rates of local recurrence with the omission of radiotherapy even in “l(fā)ow-risk” patient

ensemble

留戀

Role of Genetic Profiling and Recurrence Scores in Treatment Planning for DCIS,th improvements in technology, has led to the identification of large numbers of women with DCIS, many of which are detected at relatively small sizes. However, significant debate surrounds the proper management of patients with DCIS who are eligible for breast-conserving therapy. Some advocate for

Headstrong

Nmda-Receptor

Role of Postmastectomy Radiation for DCIS,asive breast cancer, the possible role of postmastectomy radiation for ductal carcinoma in situ (DCIS) remains unclear. Here, we examine the data that may be relevant to inform decisions regarding the potential indications, benefits, and side effects of postmastectomy radiation for DCIS, including d